Correlation Between Lyell Immunopharma and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Lyell Immunopharma and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Enanta Pharmaceuticals.
Diversification Opportunities for Lyell Immunopharma and Enanta Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyell and Enanta is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Enanta Pharmaceuticals
Given the investment horizon of 90 days Lyell Immunopharma is expected to generate 2.16 times less return on investment than Enanta Pharmaceuticals. In addition to that, Lyell Immunopharma is 1.01 times more volatile than Enanta Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest 585.00 in Enanta Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of 1.00 from holding Enanta Pharmaceuticals or generate 0.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Lyell Immunopharma vs. Enanta Pharmaceuticals
Performance |
Timeline |
Lyell Immunopharma |
Enanta Pharmaceuticals |
Lyell Immunopharma and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lyell Immunopharma and Enanta Pharmaceuticals
The main advantage of trading using opposite Lyell Immunopharma and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bonds Directory Find actively traded corporate debentures issued by US companies |